Low‐dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success

INTRODUCTION: Immune Tolerance Induction (ITI) is the first‐choice therapy to eradicate Factor VIII (FVIII) neutralizing antibodies in patients with haemophilia A (HA). There is limited published data on ITI from East Mediterranean countries. AIM: To assess the effectiveness of a low‐dose ITI regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Elalfy, Mohsen, Elghamry, Islam, Hassab, Hoda, Elalfy, Omar, Andrawes, Nevine, El‐Ekiaby, Magdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299496/
https://www.ncbi.nlm.nih.gov/pubmed/34797008
http://dx.doi.org/10.1111/hae.14456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299496/
https://www.ncbi.nlm.nih.gov/pubmed/34797008
http://dx.doi.org/10.1111/hae.14456

Ejemplares similares